CSL Lifts Profit Guidance
CSL Limited today announced a revised profit outlook for fiscal 2018.
World Haemophilia Day
CSL Behring Marks World Haemophilia Day by Shipping Bleeding Disorders Medicines to t…
1st Patient Enrollment in CSL112 Trial
The AEGIS-II trial will enrol more than 17,000 patients from approximately 1,000 medi…
Making Forbes’ Top Global Employers List
Global biotech leader rated at no. 42 for patient focus, innovation and sustainable g…
We are passionate about people
Senior Vice President and General Manager, CSL Plasma
When Mike Deem joined CSL nearly 30 years ago, he was a college student in search of tuition reimbursement. That college job turned into an exciting career. He's now SVP and General Manager of CSL Plasma and credits his success to the mentors and development opportunities provided by the company.